A case of SARS-CoV-2 treatment with remdesivir in a hepatitis C coinfected patient resulting in temporary viral control and post-treatment flare

We report a case of a man with chronic hepatitis C infection treated with remdesivir for COVID-19, resulting in lowered HCV viral load, followed by a rebound after its discontinuation. Concomitant treatment with tocilizumab possibly caused loss of anti-HBs.